Pfizer CEO Bourla reconsiders German investments as industry takes aim at healthcare reform plan: Reuters

Germany’s new healthcare reform initiative has already led two global drugmakers to slice their planned investments in the country. The CEO voiced his concerns about Germany's new healthcare reform plan in a letter to Chancellor Friedrich Merz, according to reports.

Source: FiercePharma